Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma

2022 ◽  
Author(s):  
Xi-zhi Wen ◽  
Qiu-zhong Pan ◽  
Bu-shu Xu ◽  
Wei Xiao ◽  
De-sheng Weng ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin

Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicin

2006 ◽  
Vol 86 (3) ◽  
pp. 211-216 ◽  
Author(s):  
Suzanne E. Biehn ◽  
Dominic T. Moore ◽  
Peter M. Voorhees ◽  
Reynaldo A. Garcia ◽  
Mary Jo Lehman ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Phase I ◽  
Outcome Measures ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin

scholarly journals Phase I Study of Combined Pegylated Liposomal Doxorubicin with Protracted Daily Topotecan for Ovarian Cancer

2005 ◽  
Vol 11 (16) ◽  
pp. 5912-5919 ◽  
Author(s):  
Deepu Mirchandani ◽  
Howard Hochster ◽  
Anne Hamilton ◽  
Leonard Liebes ◽  
Herman Yee ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin

Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma

2015 ◽  
Vol 76 (2) ◽  
pp. 425-432 ◽  
Author(s):  
Pascal Chastagner ◽  
Bénédicte Devictor ◽  
Birgit Geoerger ◽  
Isabelle Aerts ◽  
Pierre Leblond ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
High Grade Glioma ◽  
High Grade

A Phase I Study of Pegylated Liposomal Doxorubicin and Irinotecan in Patients with Solid Tumors

Chemotherapy ◽  
2009 ◽  
Vol 55 (6) ◽  
pp. 441-445 ◽  
Author(s):  
Daniel Morgensztern ◽  
Maria Q. Baggstrom ◽  
Giancarlo Pillot ◽  
Benjamin Tan ◽  
Paula Fracasso ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin

Phase I Study of Paclitaxel (Taxol) and Pegylated Liposomal Doxorubicin (Caelyx) Administered Every 2 Weeks in Patients with Advanced Solid Tumors

Oncology ◽  
2002 ◽  
Vol 62 (3) ◽  
pp. 216-222 ◽  
Author(s):  
D. Mavroudis ◽  
Ch. Kouroussis ◽  
S. Kakolyris ◽  
S. Agelaki ◽  
K. Kalbakis ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Advanced Solid Tumors

Phase I Study of Pegylated Liposomal Doxorubicin in Combination With Ifosfamide in Pretreated Ovarian Cancer Patients

2006 ◽  
Vol 29 (4) ◽  
pp. 399-404 ◽  
Author(s):  
Hugues Bourgeois ◽  
Florence Joly ◽  
Eric Pujade-Lauraine ◽  
Herv?? Cure ◽  
Jean Paul Guastalla ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin

scholarly journals A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies

2008 ◽  
Vol 19 (10) ◽  
pp. 1802-1809 ◽  
Author(s):  
M. von Mehren ◽  
R.J. Schilder ◽  
J.D. Cheng ◽  
E. Temmer ◽  
T.M. Cardoso ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Liposomal Doxorubicin ◽  
Pegylated Liposomal Doxorubicin ◽  
Advanced Malignancies
Sign in / Sign up

Export Citation Format

Share Document